Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.061.551.662.512.49

What is the latest Sales/Fixed Asset ratio of GLAND PHARMA ?

The latest Sales/Fixed Asset ratio of GLAND PHARMA is 1.06 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20251.06
Mar20241.55
Mar20231.66
Mar20222.51
Mar20212.49

How is Sales/Fixed Asset of GLAND PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.06
-31.61
Mar2024 1.55
-6.63
Mar2023 1.66
-33.86
Mar2022 2.51
0.80
Mar2021 2.49 -

Other Financial Ratios of GLAND PHARMA


Compare Sales/Fixed Asset ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹26,564.9 Cr -1.4% -12.2% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.4%

-12.2%

2.8%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses